Madopar

Levodopa/Benserazide, the active ingredient in Madopar, is a dopamine precursor and DOPA decarboxylase inhibitor presented as an oral tablet for oral use. It is employed to manage the motor symptoms of Parkinson's disease and related Parkinsonian syndromes in adult patients.

GNH USA supplies Madopar as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics across global markets with consistent quality, regulatory adherence, and reliable logistics support for patient care across continents worldwide and timely delivery.

Madopar, a dopamine precursor/DOPA decarboxylase inhibitor, is used in the management of Parkinsonian disorders.

- Parkinson's disease: improves motor function and reduces rigidity and tremor. - Parkinsonian syndrome: alleviates bradykinesia, rigidity, and gait disturbances.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: often related to orthostatic changes. - Headache: transient and usually resolves. - Insomnia: difficulty falling or staying asleep. - Orthostatic hypotension: drop in blood pressure upon standing. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations or psychosis: visual or auditory disturbances. - Severe hypotension: marked drop in blood pressure requiring medical attention. - Cardiac arrhythmias: irregular heart rhythms. - Neuroleptic malignant syndrome: life‑threatening reaction. - Anaphylaxis: acute allergic response.

Before initiating therapy, clinicians should consider several safety aspects. - Monitor blood pressure: watch for orthostatic hypotension, especially after dose changes. - Assess for dyskinesia: adjust dose if excessive involuntary movements develop. - Review psychiatric history: increased risk of hallucinations or confusion. - Avoid abrupt discontinuation: sudden stop may worsen Parkinsonian symptoms. - Use with caution in renal or hepatic impairment: dose adjustment may be required. - Store at room temperature: keep in the original pack, protect from moisture.

Madopar may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Pyridoxine (vitamin B6): enhances peripheral levodopa metabolism, reducing effect. - Antipsychotics (dopamine antagonists): may diminish therapeutic benefit.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: additive blood‑pressure lowering effect. - Selective serotonin reuptake inhibitors (SSRIs): potential for serotonin syndrome. - Iron or calcium supplements: may impair levodopa absorption; separate dosing times.